Login
Support
Search
Search
Lakshminarayana Vogeti
Appearances
View Grid
Discovery of vimseltinib (DCC-3014), a highly selective switch-control inhibitor of CSF1R kinase
Date
April 9, 2021
Vimseltinib (DCC-3014) is an oral switch-control tyrosine kinase inhibitor specifically designed to selectively and potently inhibit colony-stimulating factor 1 receptor (CSF1R) kinase…
Presenter
Timothy M. Caldwell
,
Ph.D.
Principal Investigator, Chemistry
,
Deciphera Pharmaceuticals, LLC
Speakers
Yu Ahn
Gary Brandt
Lara Davis
Michael Kaufman
Keisuke Kuida
Cynthia Leary
Wei Ping Lu
William Patt
Thiwanka Samarakoon
Rodrigo Ruiz-Soto
Maitreyi Sharma
Matthew Sherman
Gege Tan
Lakshminarayana Vogeti
Subha Vogeti
Breelyn Wilky
Karen Yates
Bryan Smith
Daniel Flynn